SCHEMBL752158

SCHEMBL752158

COC(=O)c1ccc(CNC(=O)c2ccc([C@@H](C)[C@@](O)(c3ccnc(Cl)c3)C(F)(F)F)c(Cl)c2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RORC P51449 1/20 0.44
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
ALDH1A1 P00352 7/20 0.41
HPGD P15428 6/20 0.41
CYP2C9 P11712 5/20 0.41
CYP2C19 P33261 4/20 0.41
CYP1A2 P05177 3/20 0.41
CYP2D6 P10635 3/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
KDM4E B2RXH2 5/20 0.40
EPHX2 P34913 2/20 0.40
GAA P10253 1/20 0.40
KDM1A O60341 2/20 0.39
HDAC1 Q13547 2/20 0.39
CYP3A4 P08684 2/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
CFTR P13569 1/20 0.38
NR1H4 Q96RI1 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL479857 1.00 RORC (0.44) RORCNPC1RAB9AALDH1A1HPGD
SCHEMBL754329 0.92 EPHX2 (0.49) RORCEPHX2KDM1AHDAC1NR1H4
SCHEMBL479656 0.92 EPHX2 (0.49) RORCEPHX2KDM1AHDAC1NR1H4
SCHEMBL479894 0.90 NR1H4 (0.44) RORCRAB9AALDH1A1HPGDCYP2C9
SCHEMBL752950 0.90 NR1H4 (0.44) RORCRAB9AALDH1A1HPGDCYP2C9
SCHEMBL479539 0.89 LMNA (0.41) ALDH1A1HPGDCYP2C9CYP2C19CYP1A2
SCHEMBL753180 0.89 LMNA (0.41) ALDH1A1HPGDCYP2C9CYP2C19CYP1A2
SCHEMBL480160 0.88 PDK1 (0.43) ALDH1A1CYP2C9CYP2C19CYP1A2SMN1; SMN2
SCHEMBL480861 0.87 MAPT (0.44) NPC1RAB9AALDH1A1HPGDSMN1; SMN2
SCHEMBL755473 0.85 ROCK2 (0.39) NPC1RAB9AALDH1A1SMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138189-B2 Substituted benzene compounds as modulators of the glucocorticoid receptor HOFFMAN-LA ROCHE INC. (US) 2012-03-20 US disclosed
US-8138189-B2 Substituted benzene compounds as modulators of the glucocorticoid receptor HOFFMAN-LA ROCHE INC. (US) 2012-03-20 US disclosed
US-20100249139-A1 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS HOFFMANN-LA ROCHE, INC. 2010-09-30 US disclosed
US-20100249139-A1 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS HOFFMANN-LA ROCHE, INC. 2010-09-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100249139-A1 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS NR3C1, NR3C2, CRHR1 RORC 250/4885NPC1 524/4885RAB9A 1623/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.